2RUSTIN GJ,QUINN M,THIGPEN T,et al.New guide-lines to evaluate the response to treatment in solid tumors(ovarian cancer)[J].J Natl Cancer Inst,2004,96:487-488.
3VERGOTE I,RUSTIN GJ,EISENHAUER EA,et al.Newguidelines to evaluate the response to treatment in solidtumors(ovarian cancer)gynecologic cancer intergroup[J].J Natl Cancer Inst,2000,92:1534-1535.
5SHAPIRO JD,MILLWARD MJ,RISCHIN D,et al.Activityof gemcitabine in patients with advanced ovarian cancer:responses seen following platinum and paclitaxel[J].Gynecol Oncol,1996,63(1):89-93.
6MOUFARU MA,PHILLIPS DR,CULUNANE C.Gemc-itabine potentiates cisplatin cytotoxicity and inhibits repair ofcisplatin-DNA damage in ovarian cancer cell lines[J].MolPharmacol,2003,63(4):862-869.
7TEWARI D,MONK BJ,HUNTER M,et al.Gemcitabineand cisplatin chemotherapy is an active combination in thetreatment of platinum resistant ovarian and peritonealcarcinoma[J].Invest New Drugs,2004,22(4):475-480.
